The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer.

导出 OA

翻译打印收藏纠错

第一作者： Xin,Luo

第一单位： Department of General Surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China.

作者： Xin,Luo ^[1] ; Xianchao,Lin ^[1] ; Ronggui,Lin ^[1] ; Yuanyuan,Yang ^[1] ; Congfei,Wang ^[1] ; Haizong,Fang ^[1] ; Heguang,Huang ^[1] ; Fengchun,Lu ^[2]

作者单位： Department of General Surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China. ^[1] Department of General Surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, 350001, Fujian, China. fengchun160@fjmu.edu.cn. ^[2]

关键词 CA125 Early recurrence Resectable pancreatic cancer

主题词人类(Humans);预后(Prognosis);CA-125抗原(CA-125 Antigen);胰腺肿瘤(Pancreatic Neoplasms);手术后期间(Postoperative Period)

DOI 10.1186/s12885-023-11346-8

PMID 37670245

发布时间 2023-12-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交